Literature DB >> 16012846

Chromosomal alterations in early stages of malignant mesotheliomas.

Frank Simon1, Georg Johnen, Michael Krismann, Klaus-Michael Müller.   

Abstract

In a case of a 67-year-old man with two different early stages of a predominantly epithelioid mesothelioma ("mesothelioma in situ", "early-stage mesothelioma"), chromosomal imbalances were determined by comparative genomic hybridisation (CGH), a molecular cytogenetic technique to detect chromosomal gains and losses in tumour cells. In the case of the mesothelioma in situ cells, nine different chromosomal alterations could be detected (losses on 3p, 5q, 6q, 8p, 9p, 15q, 22q, Y; gain on 7q), whereas the early-stage mesothelioma showed the same defects except for the gain on 7q. The simultaneous losses of 6q, 9p and 22q, as well as other chromosomal regions, correlate well with the most common defects previously found in 90 cases of more-advanced-stage mesotheliomas using CGH. These data demonstrate that initial chromosomal defects in early stages of mesotheliomas can be detected by conventional CGH in combination with laser microdissection. The molecular cytogenetic findings support the histological diagnosis of a pleural mesothelioma. The surprisingly high number and extent of genomic alterations found in the examined case probably reflects the genomic instability in the tumour cells and indicates a "genetic chaos" even in earlier stages of malignant mesotheliomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012846     DOI: 10.1007/s00428-005-0005-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.

Authors:  H Telenius; N P Carter; C E Bebb; M Nordenskjöld; B A Ponder; A Tunnacliffe
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

2.  Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.

Authors:  Holger Schipper; Thilo Papp; Georg Johnen; Heidi Pemsel; Ralf Bastrop; Klaus-Michael Müller; Thorsten Wiethege; Malgorzata Jaworska; Michael Krismann; Dietmar Schiffmann; Qamar Rahman
Journal:  Int J Oncol       Date:  2003-05       Impact factor: 5.650

3.  Patterns of chromosomal imbalances in benign solitary fibrous tumours of the pleura.

Authors:  M Krismann; H Adams; M Jaworska; K M Müller; G Johnen
Journal:  Virchows Arch       Date:  2000-09       Impact factor: 4.064

4.  Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.

Authors:  T Kuukasjärvi; M Tanner; S Pennanen; R Karhu; T Visakorpi; J Isola
Journal:  Genes Chromosomes Cancer       Date:  1997-02       Impact factor: 5.006

Review 5.  New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

Authors:  Anna K Nowak; Richard A Lake; Hedy Lee Kindler; Bruce W S Robinson
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

6.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

Authors:  V W Rusch
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

7.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B.

Authors:  Sandra Hanks; Kim Coleman; Sarah Reid; Alberto Plaja; Helen Firth; David Fitzpatrick; Alexa Kidd; Károly Méhes; Richard Nash; Nathanial Robin; Nora Shannon; John Tolmie; John Swansbury; Alexandre Irrthum; Jenny Douglas; Nazneen Rahman
Journal:  Nat Genet       Date:  2004-10-10       Impact factor: 38.330

Review 8.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  Comparative genomic hybridization: a new tool in cancer pathology.

Authors:  M A Hermsen; G A Meijer; J P Baak; H Joenje; J J Walboomers
Journal:  Hum Pathol       Date:  1996-04       Impact factor: 3.466

10.  Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Authors:  A M Björkqvist; L Tammilehto; S Nordling; M Nurminen; S Anttila; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  2 in total

1.  [Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].

Authors:  M Krismann; P Thattamparambil; F Simon; G Johnen
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

Review 2.  Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.

Authors:  Luigina Micolucci; Most Mauluda Akhtar; Fabiola Olivieri; Maria Rita Rippo; Antonio Domenico Procopio
Journal:  Oncotarget       Date:  2016-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.